Difference between revisions of "Williamson"

(Imported from Wikispaces)
 
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
−
==<span style="font-size: 140%;">No data on the use of hyperbaric oxygen for open tibial fractures</span>==
+
 
−
==<span style="font-size: 12pt;">Clinical bottom line:</span>==
+
<span style="line-height:normal">'''<span style="font-size:18.0pt"><span style="font-family:">No data on the use of hyperbaric oxygen for open tibial fractures</span></span>'''</span>
−
{|  
+
 
−
| '''1. Trial abandoned having recruited only 17 patients in total (target 36 in each group)'''
+
<span style="line-height:normal">'''<span style="font-size:14.0pt"><span style="font-family:">Clinical bottom line:</span></span>'''</span>
 +
 
 +
{| class="Table" style="border:undefined"
 
|-
 
|-
 +
|
 +
<span style="line-height:normal"><span style="font-size:14.0pt"><span style="font-family:">1. Trial abandoned having recruited only 17 patients in total (target 36 in each group)</span></span></span>
 +
 
|}
 
|}
−
**Citation/s:''' Williamson OD, Millar I, Venturoni C. Hyperbaric oxygen and the management of open tibial fractures. Journal of Bone and Joint Surgery – British Volume, Orthopaedic proceedings 2005; 88-B(Suppl II):323.
 
  
−
**Lead author's name and fax:''' O.D.Williamson, I. Millar
+
----
−
**Three-part Clinical Question:''' Does HBOT improve soft tissue healing in adult patients with open tibial fractures?
+
 
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Citation/s:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">1. Williamson OD, Millar I, Venturoni C. Hyperbaric oxygen and the management of open tibial fractures. Journal of Bone and Joint Surgery – British Volume, Orthopaedic proceedings 2005; 88-B(Suppl II):323.</span></span></span>
 +
 
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Lead author's name and fax:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">I. Millar I.Millar@alfred.org.au</span></span></span>
 +
 
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Three-part Clinical Question:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">Does HBOT improve soft tissue healing in adult patients with open tibial fractures?</span></span></span>
 +
 
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Search Terms:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">Open tibial fracture; crush injury</span></span></span>
 +
 
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">The Study:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">Non-blinded randomised controlled trial.</span></span></span>
 +
 
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">The Study Patients:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">Adults with lower leg fractures requiring extensive soft tssue and/or vascular repair (Gustillo class 3B and 3C fractures).</span></span></span>
 +
 
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Control group:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">No HBOT, usual management.</span></span></span>
 +
 
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Experimental group:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">As above plus HBOT – dose not reported.</span></span></span>
 +
 
 +
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">The Evidence:</span></span>'''</span>
  
−
**Search Terms:''' Open tibial fracture hyperbaric oxygen therapy
+
<span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">None reported.</span></span></span>
−
**The Study:'''
 
  
−
Non-blinded randomised controlled trial.
+
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Comments:</span></span>'''</span>
  
−
**The Study Patients:''' Adults with lower leg fractures requiring extensive soft tssue and/or vascular repair (Gustillo class 3B and 3C fractures).
+
<span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">1. Reasons for cancellation given were slower than expected recruitment rate and difficulty engaging orthopaedic team owing to pre-existing belief that HBO was efficacious.</span></span></span>
  
−
**Control group''': No HBOT, usual management.
+
<span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">2. No report of any outcome from the 17 enrolled patients.</span></span></span>
  
−
**Experimental group''': As above plus HBOT – dose not reported
+
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Appraised by:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">Craig Wilson c.c.wilson@live.co.uk; Friday, 24 November 2017</span></span></span>
−
**The Evidence:'''
 
−
None reported.
 
−
**Comments:'''
 
  
−
1. Reasons for cancellation given were slower than expected recruitment rate and difficulty engaging orthopaedic team owing to pre-existing belief that HBO was efficacious.
+
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Email:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">c.c.wilson@live.co.uk</span></span></span>
−
2.No report of any outcome from the 17 enrolled patients.
 
−
**Appraised by:''' Craig Wilson c.c.wilson@live.co.uk; Friday, 24 November 2017
 
  
−
Email: c.c.wilson@live.co.uk
+
<span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Kill or Update By:</span></span>'''<span style="font-size:12.0pt"><span style="font-family:">November 2022</span></span></span>
  
−
**Kill or Update By:''' November 2020
+
[[File:Sumhorsa.gif|center|sumhorsa.gif]]
  
−
[[File:sumhorsa.gif|center|sumhorsa.gif]]
+
== <span style="display: block; text-align: center;"><span style="color: #7c00ff; font-size: 160%;">[[Crush_injuries|BACK]]</span></span> ==
  
−
==<span style="display: block; text-align: center;"><span style="color: #7c00ff; font-size: 160%;">[[Acute ischaemia  |  BACK]]</span></span>==
+
&nbsp;
−
<span style="display: block; text-align: center;">
 
−
</span>
 

Latest revision as of 22:56, 23 August 2022

No data on the use of hyperbaric oxygen for open tibial fractures

Clinical bottom line:

1. Trial abandoned having recruited only 17 patients in total (target 36 in each group)


Citation/s:1. Williamson OD, Millar I, Venturoni C. Hyperbaric oxygen and the management of open tibial fractures. Journal of Bone and Joint Surgery – British Volume, Orthopaedic proceedings 2005; 88-B(Suppl II):323.

Lead author's name and fax:I. Millar I.Millar@alfred.org.au

Three-part Clinical Question:Does HBOT improve soft tissue healing in adult patients with open tibial fractures?

Search Terms:Open tibial fracture; crush injury

The Study:Non-blinded randomised controlled trial.

The Study Patients:Adults with lower leg fractures requiring extensive soft tssue and/or vascular repair (Gustillo class 3B and 3C fractures).

Control group:No HBOT, usual management.

Experimental group:As above plus HBOT – dose not reported.

The Evidence:

None reported.

Comments:

1. Reasons for cancellation given were slower than expected recruitment rate and difficulty engaging orthopaedic team owing to pre-existing belief that HBO was efficacious.

2. No report of any outcome from the 17 enrolled patients.

Appraised by:Craig Wilson c.c.wilson@live.co.uk; Friday, 24 November 2017

Email:c.c.wilson@live.co.uk

Kill or Update By:November 2022

sumhorsa.gif

BACK